Analytical Test Series Would Allow Characterization Of Follow-On Biologics – GPhA
This article was originally published in The Pink Sheet Daily
Executive Summary
"No 'one' analytical method is currently capable of such comprehensive analysis," a Generic Pharmaceutical Association white paper states. Previously reported characterization problems were due to inappropriate or misinterpreted tests, GPhA maintains.